Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Condition: Overactive BladderInterventions: Drug: Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets; Drug: Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tabletsSponsor: Ferring PharmaceuticalsCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2012 Category: Research Source Type: clinical trials
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Condition: Overactive BladderInterventions: Drug: Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets; Drug: Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tabletsSponsor: Ferring PharmaceuticalsActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2012 Category: Research Source Type: clinical trials